📈 Stocks 🌍 Canada

Tecsys Reports Record Q1 Revenue of C$50 Million and Raises Fiscal 2027 Outlook

Tecsys posted record Q1 results fueled by healthcare sector expansion, prompting management to lift fiscal 2027 revenue and margin guidance as remaining performance obligations topped C$250 million.

📅 September 11, 2026 🕐 1 min read

1 assets impacted (Stocks). Net bias: 1 Bullish, 0 Bearish, 0 Neutral. Strongest signal: TCS ↑ 7/10 (68% confidence).

📊 Affected Assets (1)

TCS

Bullish 🤖 68%

📆 Mid-term 🌍 CA · Explicit

Tecsys reported record Q1 revenue and raised fiscal 2027 guidance, driven by strong healthcare-led SaaS expansion.

🎯 Key Takeaways

Total SaaS revenue grew 18% year-over-year, with Elite SaaS revenue rising 24%.
Fiscal 2027 guidance was upgraded, with Elite SaaS growth now expected at 21%–23%.
Remaining performance obligations reached a record C$259.2 million.
Healthcare deployments, including Prisma Health and UT Southwestern, served as the primary growth catalyst.

📝 Executive Summary

Tecsys Inc. (TSE:TCS) delivered a record first quarter for fiscal 2027, with revenue climbing 9% to C$50 million and adjusted EBITDA more than doubling to C$6.9 million. Driven by strong healthcare-led SaaS expansion and robust bookings, the company raised its full-year growth guidance across all key metrics, including Elite SaaS revenue and adjusted EBITDA margins.

❓ FAQ

What drove Tecsys' strong performance in the first quarter?

The growth was primarily driven by existing healthcare customers expanding their use of the Elite platform and TecsysIQ AI capabilities, alongside strong hardware demand.

📰 Related Articles

🏷️ Tags

📰 Source

🔗 View Original Article